Skip to playerSkip to main contentSkip to footer
  • 1/24/2012
Recently evidence has shown that patients taking the Type 2 Diabetes drug Actos for more than one year have a 40% increased risk of bladder cancer. Actos has been pulled from the markets in both Germany and France.

Recommended